2012-2013 Seminars

September 19, 2012
Title: Pluripotent Cell Repair of Cartilage Lesions: Promise and Challenges
Speaker: Darryl D’ Lima, M.D., Ph.D., Associate Professor, Scripps Translational Science Institute, Division of Arthritis Research, Director, Orthopedic Research Scripps Healthcare, La Jolla, CA

November 14, 2012
Title: Aspirin, NSAIDs, and Colorectal Cancer: Personalizing Chemoprevention
Speaker: Andrew T. Chan, M.D., M.P.H., Associate Professor of Medicine, Program Director, Gastroenterology Training Program, Massachusetts General Hospital, Harvard Medical School

December 12, 2012
Title: DNA Breaks are Induced Throughout the B Cell Genome During Antibody Class Switching
Speaker: Janet Stavnezer, Ph.D., Professor, University of Massachusetts Medical School, Microbiology & Physiological Systems, University of Massachusetts Medical School

January 24, 2013
Title: Role of Modified DNA Cytosines in Development and Cancer
Speaker: Gerd P. Pfeifer, Ph.D., Lester M. and Irene C. Finkelstein Chair, Department of Cancer Biology, Beckman Research Institute, City of Hope.

January 30, 2013
Title: Cancer Stem Cells: Is It Ready for Prime Time?
Speaker: Shrikant Anant, Ph.D., Tom and Teresa Walsh Professor for Cancer Prevention, Kansas Mason Professor for Cancer Research, NCI-designated University of Kansas Cancer Center, Professor of Cancer Research, Department of Molecular and Integrative Physiology, Associate Dean for Research, University of Kansas Medical Center

February 13, 2013
Title: Conditionally Reprogramming of Epithelial Cells: Advancing the Understanding and Treatment of Cancer
Speaker: Christopher Albanese, Ph.D., Associate Professor, Departments of Oncology and Pathology, Director, Preclinical Imaging Research Laboratory (PIRL), Director of Experimental Pathology, Associate Editor, American Journal of Pathology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center

March 27, 2013
Title: Oncogenomics of B Cell Malignancies
Speaker: Riccardo Dalla-Favera, M.D., Director, Institute for Cancer Genetics, Irving Cancer Research Center, Columbia University, New York

April 3,  2013
Title: Innovation In Biomedicine – The Big Picture
Speaker: Michael Rosenblatt, M.D., Executive Vice President and Chief Medical Officer, Merck & Co., Inc.